Formulation and characterization of clozapine and risperidone co-entrapped spray-dried PLGA nanoparticles

References

• Pardridge WM. Blood–brain barrier drug targeting: the future of brain drug development. Mol Interv 2003;3:90–105
   PubMedGoogle Scholar
• Garcia-Garcia E, Andrieux K, Gil S, Couvreur P. Colloidal carriers and blood–brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int J Pharm 2005;298:274–292
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV. New technologies for drug delivery across the blood–brain barrier. Curr Pharm Des 2004;10:1355–1363
   PubMed Web of Science ®Google Scholar
• Roney C, Kulkarni P, Arora V, et al. Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer’s disease. J Control Release 2005;108:193–214
   PubMed Web of Science ®Google Scholar
• Kreuter J. Nanoparticles – a historical perspective. Int J Pharm 2007;331:1–10
   PubMed Web of Science ®Google Scholar
• Olivier JC. Drug transport to brain with targeted nanoparticles. NeuroRx 2005;2:108–119
   PubMedGoogle Scholar
• Schroeder U, Sommerfeld P, Ulrich S, Sabel BA. Nanoparticle technology for delivery of drugs across the blood–brain barrier. J Pharm Sci 1998;87:1305–1307
   PubMed Web of Science ®Google Scholar
• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 2006;58:1688–1713
   PubMed Web of Science ®Google Scholar
• Vehring R. Pharmaceutical particle engineering via spray-drying. Pharm Res 2008;25:999–1022
   PubMed Web of Science ®Google Scholar
• Cal K, Sollohub K. Spray-drying technique. I. Hardware and process parameters. J Pharm Sci 2010;99:575–586
   PubMed Web of Science ®Google Scholar
• Sollohub K, Cal K. Spray-drying technique. II. Current applications in pharmaceutical technology. J Pharm Sci 2010;99:587–597
   PubMed Web of Science ®Google Scholar
• Pohlmann AR, Weiss V, Mertins O, et al. Spray-dried Indomethacin-loaded polyester nanocapsules and nanospheres: development. Stability evaluation and nanostructure models. Eur J Pharm Sci 2002;16:305–312
   PubMed Web of Science ®Google Scholar
• Li X, Anton N, Arpagaus C, et al. Nanoparticles by spray-drying using innovative new technology: the Buchi nano spray dryer B-90. J Control Release 2010;147:304–310
   PubMed Web of Science ®Google Scholar
• Peltonen L, Valo H, Kolakovic R, et al. Electrospraying, spray drying and related techniques for production and formulation of drug nanoparticles. Expert Opin Drug Deliv 2010;7:705–719
   PubMed Web of Science ®Google Scholar
• Beck-Broichsitter M, Schweiger C, Schmehl T, et al. Characterization of novel spray dried polymeric particles for controlled pulmonary drug delivery. J Control Release 2012;158:329–335
   PubMed Web of Science ®Google Scholar
• Fields JH, Grochowski S, Lindenmayer JP, et al. Assessing positive and negative symptoms in children and adolescents. Am J Psychiatry 1994;151:249–253
   PubMed Web of Science ®Google Scholar
• Kane JM. Treatment-resistant schizophrenic patients. J Clin Psychiatry 1996;57:35–40
   PubMed Web of Science ®Google Scholar
• Grunder G, Hippius H, Carlsson A. The ‘atypicality’ of antipsychotics: a concept re-examined and re-defined. Nat Rev Drug Discov 2009;8:197–202
   PubMed Web of Science ®Google Scholar
• Chakos M, Lieberman J, Hoffman E, et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry 2001;158:518–526
   PubMed Web of Science ®Google Scholar
• Henderson DC, Goff DC. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics. J Clin Psychiatry 1996;57:395–397
   PubMed Web of Science ®Google Scholar
• Morera AL, Barreiro P, Cano-Munoz JL. Risperidone and clozapine combination for the treatment of refractory schizophrenia. Acta Psychiatr Scand 1999;99:305–306
   PubMed Web of Science ®Google Scholar
• Raskin S, Katz G, Zislin Z, et al. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation. Acta Psychiatr Scand 2000;101:334–336
   PubMed Web of Science ®Google Scholar
• Fleischhacker WW, Hummer M, Kurz M, et al. Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects. J Clin Psychiatry 1994;55B:78–81
   Google Scholar
• D’Souza S, Faraj J, DeLuca P. Microsphere delivery of Risperidone as an alternative to combination therapy. Eur J Pharm Biopharm 2013;85:631–639
   PubMed Web of Science ®Google Scholar
• Hasan NY, Elkawy MA, Elzeany BE, Wagieh NE. Stability indicating methods for the determination of clozapine. J Pharm Biomed Anal 2002;30:35–47
   PubMed Web of Science ®Google Scholar
• Leroueil-Le VM, Fluckiger L, Kim YI, et al. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm 1998;46:137–143
   PubMed Web of Science ®Google Scholar
• Dubernet C. Thermoanalysis of microspheres. Thermochim Acta 1995;248:259–269
   Web of Science ®Google Scholar
• Nanjwade BK, Singh J, Parikh KA, Manvi FV. Preparation and evaluation of carboplatin biodegradable polymeric nanoparticles. Int J Pharm 2010;385:176–180
   PubMed Web of Science ®Google Scholar
• Lacoulonche F, Gamisans F, Chauvet A, et al. Stability and in vitro drug release of flurbiprofen-loaded poly-epsilon-caprolactone nanospheres. Drug Dev Ind Pharm 1999;25:983–993
   PubMed Web of Science ®Google Scholar
• Zhou S, Zheng X, Yu X, et al. Hydrogen bonding interaction of poly (d,l-lactide) hydroxyapatite nanocomposites. Chem Mater 2007;19:247–253
   Web of Science ®Google Scholar
• Huang J, Wigent JR, Schwartz BJ. Drug polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend. J Pharm Sci 2008;97:252–262
   Web of Science ®Google Scholar
• Ricci M, Blasi P, Giovagnoli S, et al. Ketoprofen controlled release from composite microcapsules for cell encapsulation: effect on post-transplant acute inflammation. J Control Release 2005;107:395–407
   PubMed Web of Science ®Google Scholar
• Muller RH, Heinemann S. Photon correlation spectroscopy and zeta potential characterization of model particles and colloidal drug carriers – essential information for the interpretation of cell culture studies. Biochem Soc Trans 1991;19:502
   PubMed Web of Science ®Google Scholar
• Faisant N, Siepmann J, Benoit JP. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur J Pharm Sci 2002;15:355–366
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Leary PE, Burgess DJ. Elevated temperature accelerated release testing of PLGA microspheres. J Control Release 2006;112:293–300
   PubMed Web of Science ®Google Scholar
• Lambeng N, Michel PP, Brugg B, et al. Mechanisms of apoptosis in PC12 cells irreversibly differentiated with nerve growth factor and cyclic AMP. Brain Res 1999;821:60–68
   PubMed Web of Science ®Google Scholar
• Vehring R. Pharmaceutical particle engineering via spray-drying. Pharm Res 2008;25:999–1022
   PubMed Web of Science ®Google Scholar
• Schafroth N, Arpagaus C, Jadhav YU, et al. Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process. Colloids Surf B Biointerfaces 2012;90:8–15
   PubMed Web of Science ®Google Scholar
• Lee SH, Heng D, Ng WK, et al. Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy. Int J Pharm 2011;403:192–200
   PubMed Web of Science ®Google Scholar
• Zhang G, David A, Wiedmann TS. Performance of the vibrating membrane aerosol generation device: Aeroneb Micropump Nebulizer. J Aerosol Med 2007;20:408–416
   PubMedGoogle Scholar
• Bain DF, Munday DL, Smith A. Modulation of rifampicin release from spray-dried microspheres using combinations of poly-(dl-lactide). J Microencapsul 1999;16:369–385
   PubMed Web of Science ®Google Scholar
• Bain DF, Munday DL, Smith A. Solvent influence on spray-dried biodegradable microspheres. J Microencapsul 1999;16:453–474
   PubMed Web of Science ®Google Scholar
• Polakovic M, Gorner T, Gref R, Dellacherie E. Lidocaine loaded biodegradable nanospheres. II. Modeling of drug release. J Control Release 1999;60:169–177
   PubMed Web of Science ®Google Scholar
• Jaraswekin S, Prakongpan S, Bodmeier R. Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles. J Microencapsul 2007;24:117–128
   PubMed Web of Science ®Google Scholar